Pfizer INDovation 2025 — Frequently Asked Questions
Answers to the questions founders most often ask about Pfizer INDovation 2025 — who qualifies, the funding amount, required documents and how the application works.
Frequently asked questions
How much funding is offered under Pfizer INDovation 2025?
Selected startups receive grant funding of up to ₹60 lakhs.
What is the application deadline for Pfizer INDovation 2025?
The deadline to apply is September 30, 2025.
What stages of startups are eligible for this program?
Startups with a clinical study-ready prototype (TRL 4-5) or a market-ready product with regulatory approval (TRL 8) are eligible.
Which sectors does the program focus on?
The program addresses healthcare challenges in non-communicable diseases (NCDs), oncology, brain health, maternal and child health, and immunisation.
Does the program take equity?
The funding is provided as a grant, which is non-dilutive and does not require giving up equity.
What kind of support does the program offer besides funding?
Selected startups receive mentorship, clinical validation support, pilot deployment opportunities, and an 18-month customized acceleration program.
How are applications evaluated?
Applications are evaluated by a Grand Jury in November 2025, with results declared shortly after.
How many startups are selected?
The program aims to accelerate 14 startups.
Is DPIIT or MSME registration required to apply?
The eligibility criteria do not specify a requirement for DPIIT or MSME registration.
How can I apply for Pfizer INDovation 2025?
Applications are submitted online via the official program link: https://indovation25.innovatealpha.org?utm_source=startupgrantsindia.com
Who is eligible to apply for Pfizer INDovation 2025?
Pfizer INDovation 2025 is open to startups at any stage. It is open to startups registered anywhere in India.
Who offers Pfizer INDovation 2025?
Pfizer INDovation 2025 is offered by Pfizer India, a corporate programme. It is provided as non-dilutive funding.